Ethinylestradiol/gestodene

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 23:46, 26 December 2019. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ethinylestradiol/gestodene
Ethinylestradiol
Gestodene
Combination of
EthinylestradiolEstrogen
GestodeneProgestogen; Progestin
Clinical data
Trade namesFemodene, Gynera, Harmonet, Lindynette, Logest, Meliane, Minesse, Minulet, Mirelle, others
Other namesEE/GSD
Routes of
administration
By mouth
Drug classEstrogen; Progestin; Progestogen
Legal status
Legal status

Ethinylestradiol/gestodene (EE/GSD), sold under the brand names Femodene and Minulet among others, is a combination of ethinylestradiol (EE), an estrogen, and gestodene (GSD), a progestin, which is used as a birth control pill to prevent pregnancy in women.[1][2] It is taken by mouth and contains 20 or 30 μg EE and 0.075 mg GSD per tablet.[1][2] EE/GSD is marketed widely throughout the world.[3]

See also

References

  1. ^ a b IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 440–. ISBN 978-92-832-1291-1.
  2. ^ a b Andrzej Bartke; Andrew Constanti (9 July 2003). Basic Endocrinology. Taylor & Francis. pp. 128–. ISBN 978-1-135-29850-0.
  3. ^ https://www.drugs.com/international/gestodene.html